Grant: Discovery Grants Program - Individual
Toronto Metropolitan University
$24,000.00
Magnetic Resonance Tools for Fetal Developmental and Metabolic Assessment
EF 2024-25
Résumé
The same physics principles of magnetic resonance, which allow acquiring high-resolution, high-contrast, 3-dimensional images of soft tissue, could also be harnessed to acquire functional information about the tissue, such as its metabolite concentrations and transport.
One such approach is MR Spectroscopy (MRS). When applied to samples of amniotic fluid (AF), MRS has been shown to reveal information about markers of fetal organ development, primarily the lungs and kidneys. However, acquiring an AF sample still requires an invasive procedure to extract AF (via amniocentesis), which inadvertently increases the risk of an infection and preterm delivery. In the proposed research we will develop an MRS protocol that allows for non-invasive in-vivo interrogations of amniotic fluid (AF), thereby creating a safer alternative technique for assessing fetal lung and kidney maturity, allowing for early identification of developmental delays in the fetus.
Another approach that utilizes spectral assessment is Chemical Exchange Saturation Transfer (CEST) MRI, which relies on natural transfer of magnetization from low-concentration metabolites to the abundant water molecules. Continuous magnetic saturation and transfer between a chosen metabolite and water allows for amplification of the metabolite such that it is more easily detected through spectroscopy and can be used to trace its transport and metabolism. Applying this technique to glucose, a method termed glucoCEST, has been shown to provide information about brain metabolic rate in adults. In the proposed research we will develop glucoCEST as a non-invasive tool for evaluating fetal organ metabolic rate.
Together, glucoCEST and AF-MRS will supplement classical fetal MR imaging, providing safe and innovative means of assessing fetal organ maturity and metabolic function. We will validate their use on animal models of healthy human gestation and using a clinical-grade MRI scanner, thereby providing the first proof of principle of their potential translation to clinical utility. These techniques will revolutionize the medical imaging field through the addition of novel techniques for probing physiology in a variety of species during prenatal development. These techniques will also contribute to the medical field by facilitating early detection of developmental and functional deficits prenatally.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-04155
Name nom
Sussman, Dafna
Department département
Electrical, Computer and Biomedical Engineering - Electrical, Computer and Biomedical Engineering
Organization id
43
Institution établissement
Toronto Metropolitan University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2018
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3113
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biophysics
Research subject fr
Biophysique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Magnetic Resonance Tools for Fetal Developmental and Metabolic Assessment
Keywords
magnetic resonance; spectroscopy; chemical exchange saturation transfer; physiology; organ development; metabolism; biomedical techniques
Application summary
The same physics principles of magnetic resonance, which allow acquiring high-resolution, high-contrast, 3-dimensional images of soft tissue, could also be harnessed to acquire functional information about the tissue, such as its metabolite concentrations and transport.
One such approach is MR Spectroscopy (MRS). When applied to samples of amniotic fluid (AF), MRS has been shown to reveal information about markers of fetal organ development, primarily the lungs and kidneys. However, acquiring an AF sample still requires an invasive procedure to extract AF (via amniocentesis), which inadvertently increases the risk of an infection and preterm delivery. In the proposed research we will develop an MRS protocol that allows for non-invasive in-vivo interrogations of amniotic fluid (AF), thereby creating a safer alternative technique for assessing fetal lung and kidney maturity, allowing for early identification of developmental delays in the fetus.
Another approach that utilizes spectral assessment is Chemical Exchange Saturation Transfer (CEST) MRI, which relies on natural transfer of magnetization from low-concentration metabolites to the abundant water molecules. Continuous magnetic saturation and transfer between a chosen metabolite and water allows for amplification of the metabolite such that it is more easily detected through spectroscopy and can be used to trace its transport and metabolism. Applying this technique to glucose, a method termed glucoCEST, has been shown to provide information about brain metabolic rate in adults. In the proposed research we will develop glucoCEST as a non-invasive tool for evaluating fetal organ metabolic rate.
Together, glucoCEST and AF-MRS will supplement classical fetal MR imaging, providing safe and innovative means of assessing fetal organ maturity and metabolic function. We will validate their use on animal models of healthy human gestation and using a clinical-grade MRI scanner, thereby providing the first proof of principle of their potential translation to clinical utility. These techniques will revolutionize the medical imaging field through the addition of novel techniques for probing physiology in a variety of species during prenatal development. These techniques will also contribute to the medical field by facilitating early detection of developmental and functional deficits prenatally.